{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T11:06:16Z","timestamp":1789729576532,"version":"4.0.1"},"reference-count":96,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["FRN-204063, FRN-143345, FRN-183775, FRN-208415"],"award-info":[{"award-number":["FRN-204063, FRN-143345, FRN-183775, FRN-208415"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004376","name":"Terry Fox Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004376","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015803","name":"BC Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015803","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004410","name":"European Molecular Biology Organization","doi-asserted-by":"publisher","award":["ALTF 413-2026"],"award-info":[{"award-number":["ALTF 413-2026"]}],"id":[{"id":"10.13039\/100004410","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Tertiary lymphoid structures (TLS) are ectopic immune aggregates that form in response to chronic inflammation, and their presence across many solid tumors has been associated with improved survival and enhanced responses to immunotherapy. Although current models primarily characterize TLS through the lens of immune aggregation and organization, their formation also depends on reciprocal interactions with the non-immune tumor microenvironment. Fibroblasts, vasculature, extracellular matrix architecture, and tumor metabolism collectively influence TLS development, suggesting that these structures function as emergent tissue ecosystems rather than as immune aggregates alone. In this review, we summarize current evidence on how cancer-associated fibroblasts and the tumor vasculature regulate immune cell recruitment and organization through context-dependent expression of chemokines, adhesion molecules, structural barriers, and vascular niches, before considering how extracellular matrix remodeling and tumor metabolism further shape TLS neogenesis and maturation. Across these processes, non-immune components exhibit dual functions, promoting TLS formation in some contexts while reinforcing immune exclusion and antagonizing TLS in others. We further discuss current spatial technologies that enable in-depth quantification of TLS structure and maturity and clarify the contribution of non-immune components to TLS biology. Due to this increased appreciation of their biological relevance, we discuss the promise of non-immune components as rational targets for combination strategies to enhance TLS function and immunotherapy efficacy.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1947028","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T10:53:56Z","timestamp":1789728836000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Non-immune regulation of tertiary lymphoid structures in cancer"],"prefix":"10.3389","volume":"17","author":[{"given":"Owen K.","family":"Challen","sequence":"first","affiliation":[{"name":"Basic and Translational Research, BC Cancer Research Institute","place":["Vancouver, BC, Canada"]},{"name":"Biochemistry and Microbiology, University of Victoria","place":["Victoria, BC, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn","family":"Fitzsimons","sequence":"additional","affiliation":[{"name":"Basic and Translational Research, BC Cancer Research Institute","place":["Vancouver, BC, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wyatt W.","family":"Anderson","sequence":"additional","affiliation":[{"name":"Basic and Translational Research, BC Cancer Research Institute","place":["Vancouver, BC, Canada"]},{"name":"Pathology and Laboratory Medicine, University of British Columbia","place":["Vancouver, BC, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniella","family":"Liao","sequence":"additional","affiliation":[{"name":"Basic and Translational Research, BC Cancer Research Institute","place":["Vancouver, BC, Canada"]},{"name":"Interdisciplinary Oncology Program, University of British Columbia","place":["Vancouver, BC, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willie","family":"Wu","sequence":"additional","affiliation":[{"name":"Basic and Translational Research, BC Cancer Research Institute","place":["Vancouver, BC, Canada"]},{"name":"Interdisciplinary Oncology Program, University of British Columbia","place":["Vancouver, BC, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa G. P.","family":"Souza","sequence":"additional","affiliation":[{"name":"Basic and Translational Research, BC Cancer Research Institute","place":["Vancouver, BC, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katya H.","family":"B\u00e9nard","sequence":"additional","affiliation":[{"name":"Basic and Translational Research, BC Cancer Research Institute","place":["Vancouver, BC, Canada"]},{"name":"Interdisciplinary Oncology Program, University of British Columbia","place":["Vancouver, BC, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia R.","family":"Naso","sequence":"additional","affiliation":[{"name":"Pathology and Laboratory Medicine, University of British Columbia","place":["Vancouver, BC, Canada"]},{"name":"Pathology and Laboratory Medicine, Vancouver General Hospital","place":["Vancouver, BC, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spencer D.","family":"Martin","sequence":"additional","affiliation":[{"name":"Department of Pathology, Dalhousie University","place":["Halifax, NS, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan L.","family":"Lam","sequence":"additional","affiliation":[{"name":"Basic and Translational Research, BC Cancer Research Institute","place":["Vancouver, BC, Canada"]},{"name":"Pathology and Laboratory Medicine, University of British Columbia","place":["Vancouver, BC, Canada"]},{"name":"Interdisciplinary Oncology Program, University of British Columbia","place":["Vancouver, BC, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katey S. S.","family":"Enfield","sequence":"additional","affiliation":[{"name":"Basic and Translational Research, BC Cancer Research Institute","place":["Vancouver, BC, Canada"]},{"name":"Pathology and Laboratory Medicine, University of British Columbia","place":["Vancouver, BC, Canada"]},{"name":"Interdisciplinary Oncology Program, University of British Columbia","place":["Vancouver, BC, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41392-024-01947-5","article-title":"Tertiary lymphoid structures in diseases: immune mechanisms and therapeutic advances","volume":"9","author":"Zhao","year":"2024","journal-title":"Sig Transduct Target Ther"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.56347","article-title":"Relationship between tertiary lymphoid structure and the prognosis and clinicopathologic characteristics in solid tumors","volume":"18","author":"Zhao","year":"2021","journal-title":"Int J Med Sci"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1413067","article-title":"Mature tertiary lymphoid structures: important contributors to anti-tumor immune efficacy","volume":"15","author":"Bao","year":"2024","journal-title":"Front Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1369626","article-title":"Tertiary lymphoid structures in cancer: maturation and induction","volume":"15","author":"Chen","year":"2024","journal-title":"Front Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13045-025-01754-7","article-title":"Tertiary lymphoid structures in cancer: spatiotemporal heterogeneity, immune orchestration, and translational opportunities\u200b\u200b","volume":"18","author":"Deng","year":"2025","journal-title":"J Hematol Oncol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/s43018-022-00411-z","article-title":"Cancer-associated fibroblasts in the single-cell era","volume":"3","author":"Lavie","year":"2022","journal-title":"Nat Cancer"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00048.2019","article-title":"Diversity and biology of cancer-associated fibroblasts","volume":"101","author":"Biffi","year":"2021","journal-title":"Physiol Rev"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-019-0238-1","article-title":"A framework for advancing our understanding of cancer-associated fibroblasts","volume":"20","author":"Sahai","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109422","article-title":"Immune mechanisms orchestrate tertiary lymphoid structures in tumors via cancer-associated fibroblasts","volume":"36","author":"Rodriguez","year":"2021","journal-title":"Cell Rep"},{"key":"B10","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/imr.12748","article-title":"Fibroblastic reticular cells at the nexus of innate and adaptive immune responses","volume":"289","author":"Perez\u2010Shibayama","year":"2019","journal-title":"Immunol Rev"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/j.immuni.2023.04.014","article-title":"A local subset of mesenchymal cells expressing the transcription factor Osr1 orchestrates lymph node initiation","volume":"56","author":"Vallecillo-Garcia","year":"2023","journal-title":"Immunity"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.489","article-title":"Tertiary lymphoid structures in cancer: immune mechanisms and clinical implications","volume":"5","author":"Wang","year":"2024","journal-title":"MedComm"},{"key":"B13","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.cell.2024.10.042","article-title":"Fibroblastic reticular cells generate protective intratumoral T cell environments in lung cancer","volume":"188","author":"Onder","year":"2025","journal-title":"Cell"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/j.ccell.2026.03.004","article-title":"Myofibroblast programming blocks differentiation of TLS-organizing fibroblastic reticular cells in pancreatic cancer","volume":"44","author":"Kirschstein","year":"2026","journal-title":"Cancer Cell"},{"key":"B15","doi-asserted-by":"publisher","first-page":"7713","DOI":"10.1038\/s41467-024-52153-4","article-title":"Single-cell and spatial transcriptome analyses reveal tertiary lymphoid structures linked to tumour progression and immunotherapy response in nasopharyngeal carcinoma","volume":"15","author":"Liu","year":"2024","journal-title":"Nat Commun"},{"key":"B16","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s00262-026-04348-5","article-title":"Association of CCL21+ CAFs with B-cell recruitment and TLS maturation in penile squamous cell carcinoma","volume":"75","author":"Li","year":"2026","journal-title":"Cancer Immunol Immunother"},{"key":"B17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12943-025-02533-1","article-title":"Cancer-associated fibroblasts in the tumor microenvironment: heterogeneity, crosstalk mechanisms, and therapeutic implications","volume":"25","author":"Huang","year":"2025","journal-title":"Mol Cancer"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.64898\/2026.01.02.697439","article-title":"Spatiotemporal mapping of tertiary lymphoid structure heterogeneity shapes immune niches and clinical outcomes in intrahepatic cholangiocarcinoma","author":"Gao","year":"2026"},{"key":"B19","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.ccell.2022.04.011","article-title":"Mesothelial cell-derived antigen-presenting cancer-associated fibroblasts induce expansion of regulatory T cells in pancreatic cancer","volume":"40","author":"Huang","year":"2022","journal-title":"Cancer Cell"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1016\/j.ccell.2025.09.001","article-title":"Single-cell resolution spatial analysis of antigen-presenting cancer-associated fibroblast niches","volume":"43","author":"Chen","year":"2025","journal-title":"Cancer Cell"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20210815","article-title":"Lung tumor MHCII immunity depends on in situ antigen presentation by fibroblasts","volume":"219","author":"Kerdidani","year":"2022","journal-title":"J Exp Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2024.1403122","article-title":"Exploring the diversity of cancer-associated fibroblasts: insights into mechanisms of drug resistance","volume":"12","author":"Kazakova","year":"2024","journal-title":"Front Cell Dev Biol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-19-0094","article-title":"Cross-species single-cell analysis of pancreatic ductal adenocarcinoma reveals antigen-presenting cancer-associated fibroblasts","volume":"9","author":"Elyada","year":"2019","journal-title":"Cancer Discov"},{"key":"B24","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s43556-024-00233-8","article-title":"Cancer-associated fibroblasts: heterogeneity, tumorigenicity and therapeutic targets","volume":"5","author":"Lv","year":"2024","journal-title":"Mol BioMed"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.115432","article-title":"The tumor microenvironment is an ecosystem sustained by metabolic interactions","volume":"44","author":"Kay","year":"2025","journal-title":"Cell Rep"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.cophys.2023.100705","article-title":"Regulation, maintenance, and remodeling of high endothelial venules in homeostasis, inflammation, and cancer","volume":"36","author":"Ruddle","year":"2023","journal-title":"Curr Opin Physiol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/s12885-025-15529-3","article-title":"High endothelial venules abundance in tertiary lymphoid structures: a prognostic biomarker in non-small cell lung cancer with neoadjuvant immunochemotherapy","volume":"26","author":"Zhang","year":"2026","journal-title":"BMC Cancer"},{"key":"B28","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.ccell.2022.01.002","article-title":"Tumor-associated high endothelial venules mediate lymphocyte entry into tumors and predict response to PD-1 plus CTLA-4 combination immunotherapy","volume":"40","author":"Asrir","year":"2022","journal-title":"Cancer Cell"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-024-00728-0","article-title":"Tertiary lymphoid structures in anticancer immunity","volume":"24","author":"Teillaud","year":"2024","journal-title":"Nat Rev Cancer"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1016\/j.ccell.2022.11.002","article-title":"Cancer immunotherapies transition endothelial cells into HEVs that generate TCF1+ T lymphocyte niches through a feed-forward loop","volume":"40","author":"Hua","year":"2022","journal-title":"Cancer Cell"},{"key":"B31","doi-asserted-by":"publisher","first-page":"10435","DOI":"10.1038\/s41467-025-65421-8","article-title":"Single-cell and spatial transcriptomics implicate a prognostic function of tertiary lymphoid structures in gastric cancer","volume":"16","author":"Wang","year":"2025","journal-title":"Nat Commun"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-11-0431","article-title":"Human solid tumors contain high endothelial venules: association with T- and B-lymphocyte infiltration and favorable prognosis in breast cancer","volume":"71","author":"Martinet","year":"2011","journal-title":"Cancer Res"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2005.10.002","article-title":"Lymphotoxin-beta receptor signaling is required for the homeostatic control of HEV differentiation and function","volume":"23","author":"Browning","year":"2005","journal-title":"Immunity"},{"key":"B34","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cyto.2016.08.018","article-title":"Lymphotoxin in physiology of lymphoid tissues - implication for antiviral defense","volume":"101","author":"Koroleva","year":"2018","journal-title":"Cytokine"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.736670","article-title":"High endothelial venules: a vascular perspective on tertiary lymphoid structures in cancer","volume":"12","author":"Vella","year":"2021","journal-title":"Front Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00047","article-title":"Role of the lymphotoxin\/LIGHT system in the development and maintenance of reticular networks and vasculature in lymphoid tissues","volume":"5","author":"Lu","year":"2014","journal-title":"Front Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.191041","article-title":"VEGFD\/VEGFR2 axis induces the dedifferentiation of high endothelial venules and impairs lymphocyte homing","volume":"10","author":"Yang","year":"2025","journal-title":"JCI Insight"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2025.102200","article-title":"Interferon-responsive HEVs drive tumor tertiary lymphoid structure formation and predict immunotherapy response in nasopharyngeal carcinoma","volume":"6","author":"Liu","year":"2025","journal-title":"Cell Rep Med"},{"key":"B39","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12935-025-04161-7","article-title":"Single-cell spatial analysis identifies ID1-high endothelial cells in tertiary lymphoid structures as predictors of durable response to immunotherapy in non-small cell lung cancer","volume":"26","author":"Matsumoto","year":"2026","journal-title":"Cancer Cell Int"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1126\/science.1228456","article-title":"Interstitial dendritic cell guidance by haptotactic chemokine gradients","volume":"339","author":"Weber","year":"2013","journal-title":"Science"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00483","article-title":"Targeting chemokine\u2014glycosaminoglycan interactions to inhibit inflammation","volume":"11","author":"Crijns","year":"2020","journal-title":"Front Immunol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"3677","DOI":"10.1038\/s41467-020-17135-2","article-title":"B cell zone reticular cell microenvironments shape CXCL13 gradient formation","volume":"11","author":"Cosgrove","year":"2020","journal-title":"Nat Commun"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105003","article-title":"Tumoral and stromal hMENA isoforms impact tertiary lymphoid structure localization in lung cancer and predict immune checkpoint blockade response in patients with cancer","volume":"101","author":"Di Modugno","year":"2024","journal-title":"eBioMedicine"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3390\/polym17060822","article-title":"Extracellular matrix stiffness: mechanotransduction and mechanobiological response-driven strategies for biomedical applications targeting fibroblast inflammation","volume":"17","author":"Tiskratok","year":"2025","journal-title":"Polymers"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/ncb2756","article-title":"Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblasts","volume":"15","author":"Calvo","year":"2013","journal-title":"Nat Cell Biol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"280","DOI":"10.7150\/ijbs.121356","article-title":"Mechanical microenvironment in tumor immune evasion: bidirectional regulation between matrix stiffness and immune cells and its therapeutic implications","volume":"22","author":"Ai","year":"2026","journal-title":"Int J Biol Sci"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-024-01998-y","article-title":"Multi-omic profiling highlights factors associated with resistance to immuno-chemotherapy in non-small-cell lung cancer","volume":"57","author":"Yan","year":"2025","journal-title":"Nat Genet"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2021.1959978","article-title":"Germinal center hypoxia in tumor-draining lymph nodes negatively regulates tumor-induced humoral immune responses in mouse models of breast cancer","volume":"10","author":"Firmino","year":"2021","journal-title":"Oncoimmunology"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1601401","article-title":"Germinal center hypoxia potentiates immunoglobulin class switch recombination","volume":"197","author":"Abbott","year":"2016","journal-title":"J Immunol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1101\/2025.08.30.673054","article-title":"Lactate blocks tertiary lymphoid structure formation by inhibiting B cell chemotaxis","author":"Boulat","year":"2025"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.ccell.2025.03.011","article-title":"Spatial transcriptomics reveals tryptophan metabolism restricting maturation of intratumoral tertiary lymphoid structures","volume":"43","author":"Tang","year":"2025","journal-title":"Cancer Cell"},{"key":"B52","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.cell.2016.09.031","article-title":"L-Arginine modulates T cell metabolism and enhances survival and anti-tumor activity","volume":"167","author":"Geiger","year":"2016","journal-title":"Cell"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1172\/JCI140100","article-title":"Selective glutamine metabolism inhibition in tumor cells improves antitumor T lymphocyte activity in triple-negative breast cancer","volume":"131","author":"Edwards","year":"2021","journal-title":"J Clin Invest"},{"key":"B54","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1365-3083.1974.tb01260.x","article-title":"Organization of the invading lymphoid tissue in human lymphoid thyroiditis","volume":"3","author":"S\u00f6derstr\u00f6m","year":"1974","journal-title":"Scand J Immunol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1136\/ard.24.2.103","article-title":"Heberden oration, 1964. Some immunologic aspects of the connective tissue diseases","volume":"24","author":"Ziff","year":"1965","journal-title":"Ann Rheum Dis"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16020396","article-title":"The emerging role of tertiary lymphoid structures in breast cancer: A narrative review","volume":"16","author":"Narvaez","year":"2024","journal-title":"Cancers (Basel)"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.167.8.4710","article-title":"T cell activation in rheumatoid synovium is B cell dependent","volume":"167","author":"Takemura","year":"2001","journal-title":"J Immunol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12405","article-title":"Tertiary lymphoid structures, drivers of the anti-tumor responses in human cancers","volume":"271","author":"Dieu-Nosjean","year":"2016","journal-title":"Immunol Rev"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.52553","article-title":"Development and validation of a machine learning model for detection and classification of tertiary lymphoid structures in gastrointestinal cancers","volume":"6","author":"Li","year":"2023","journal-title":"JAMA Netw Open"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.827719","article-title":"Picturing of the lung tumor cellular composition by multispectral flow cytometry","volume":"13","author":"Olesch","year":"2022","journal-title":"Front Immunol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.4110\/in.2025.25.e38","article-title":"Comprehensive analysis of scRNA-seq and bulk RNA-seq identified TIMP1 as a prognostic marker in colorectal cancer","volume":"25","author":"Luo","year":"2025","journal-title":"Immune Netw"},{"key":"B62","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/978-1-4939-3801-8_8","article-title":"Analyzing the tumor microenvironment by flow cytometry","volume":"1458","author":"Young","year":"2016","journal-title":"Methods Mol Biol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/gm529","article-title":"Proteomic profiling of the tumor microenvironment: recent insights and the search for biomarkers","volume":"6","author":"Hanash","year":"2014","journal-title":"Genome Med"},{"key":"B64","doi-asserted-by":"publisher","first-page":"587","DOI":"10.14740\/wjon2646","article-title":"A tertiary lymphoid structure-related gene signature predicts prognosis and treatment response in hepatocellular carcinoma","volume":"16","author":"Kong","year":"2025","journal-title":"World J Oncol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1604394","article-title":"Comprehensive analysis of single-cell and bulk RNA sequencing data reveals an EGFR signature for predicting immunotherapy response and prognosis in pan-cancer","volume":"16","author":"Ye","year":"2025","journal-title":"Front Immunol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.4103\/0975-7406.100281","article-title":"Applications of immunohistochemistry","volume":"4","author":"Duraiyan","year":"2012","journal-title":"J Pharm Bioallied Sci"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24043086","article-title":"Multiplex immunofluorescence: A powerful tool in cancer immunotherapy","volume":"24","author":"Sheng","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1016\/j.ccell.2024.09.007","article-title":"The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions","volume":"42","author":"MacFawn","year":"2024","journal-title":"Cancer Cell"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-0716-4184-2_11","article-title":"Automated quantification of tertiary lymphoid structures in human tumor samples using immunofluorescence and AI-powered analysis pipeline","volume":"2864","author":"Ghamry-Barrin","year":"2025","journal-title":"Methods Mol Biol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1002\/ags3.70142","article-title":"Mature tertiary lymphoid structures indicate good chemotherapy response and prognosis in advanced colorectal cancer","volume":"10","author":"Hosoi","year":"2025","journal-title":"Ann Gastroenterol Surg"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-005531","article-title":"Maturation and abundance of tertiary lymphoid structures are associated with the efficacy of neoadjuvant chemoimmunotherapy in resectable non-small cell lung cancer","volume":"10","author":"Sun","year":"2022","journal-title":"J Immunother Cancer"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2025.152911","article-title":"A tertiary lymphoid structures-based pathological score predicts survival and recurrence in colorectal cancer patients","volume":"230","author":"Le Rochais","year":"2025","journal-title":"Immunobiology"},{"key":"B73","doi-asserted-by":"publisher","first-page":"8499","DOI":"10.1038\/s41467-025-63414-1","article-title":"Comparison of imaging based single-cell resolution spatial transcriptomics profiling platforms using formalin-fixed paraffin-embedded tumor samples","volume":"16","author":"Ozirmak Lermi","year":"2025","journal-title":"Nat Commun"},{"key":"B74","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13073-022-01075-1","article-title":"An introduction to spatial transcriptomics for biomedical research","volume":"14","author":"Williams","year":"2022","journal-title":"Genome Med"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-022-01302-5","article-title":"Deep visual proteomics defines single-cell identity and heterogeneity","volume":"40","author":"Mund","year":"2022","journal-title":"Nat Biotechnol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1877","article-title":"PD-1 regulates germinal center B cell survival and the formation and affinity of long-lived plasma cells","volume":"11","author":"Good-Jacobson","year":"2010","journal-title":"Nat Immunol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1016\/j.molcel.2024.12.023","article-title":"Deciphering functional tumor-immune crosstalk through highly multiplexed imaging and deep visual proteomics","volume":"85","author":"Zheng","year":"2025","journal-title":"Mol Cell"},{"key":"B78","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1126\/science.1104819","article-title":"Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy","volume":"307","author":"Jain","year":"2005","journal-title":"Science"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.46.3653","article-title":"Normalizing tumor microenvironment to treat cancer: Bench to bedside to biomarkers","volume":"31","author":"Jain","year":"2013","journal-title":"JCO"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aak9670","article-title":"Dual angiopoietin-2 and VEGFA inhibition elicits antitumor immunity that is enhanced by PD-1 checkpoint blockade","volume":"9","author":"Schmittnaegel","year":"2017","journal-title":"Sci Transl Med"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aak9679","article-title":"Combined antiangiogenic and anti\u2013PD-L1 therapy stimulates tumor immunity through HEV formation","volume":"9","author":"Allen","year":"2017","journal-title":"Sci Transl Med"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1816714","article-title":"Pembrolizumab plus axitinib versus sunitinib for advanced renal-cell carcinoma","volume":"380","author":"Rini","year":"2019","journal-title":"N Engl J Med"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1915745","article-title":"Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma","volume":"382","author":"Finn","year":"2020","journal-title":"N Engl J Med"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1716948","article-title":"Atezolizumab for first-line treatment of metastatic nonsquamous NSCLC","volume":"378","author":"Socinski","year":"2018","journal-title":"N Engl J Med"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2014.04.021","article-title":"Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma","volume":"25","author":"Rhim","year":"2014","journal-title":"Cancer Cell"},{"key":"B86","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.immuni.2022.02.001","article-title":"Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing plasma cells in renal cell cancer","volume":"55","author":"Meylan","year":"2022","journal-title":"Immunity"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1038\/nature25501","article-title":"TGF\u03b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells","volume":"554","author":"Mariathasan","year":"2018","journal-title":"Nature"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1320318110","article-title":"Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti\u2013PD-L1 immunotherapy in pancreatic cancer","volume":"110","author":"Feig","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-21-4141","article-title":"Cancer-associated fibroblasts suppress CD8+ T-cell infiltration and confer resistance to immune-checkpoint blockade","volume":"82","author":"Jenkins","year":"2022","journal-title":"Cancer Res"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2026.1754311","article-title":"Molecular remodeling of cancer-associated fibroblasts in breast cancer patients receiving anti\u2013PD-1 immunotherapy","volume":"16","author":"Do","year":"2026","journal-title":"Front Oncol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.cell.2009.10.027","article-title":"Matrix crosslinking forces tumor progression by enhancing integrin signaling","volume":"139","author":"Levental","year":"2009","journal-title":"Cell"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4123","article-title":"Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy","volume":"22","author":"Jiang","year":"2016","journal-title":"Nat Med"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2012.01.007","article-title":"Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma","volume":"21","author":"Provenzano","year":"2012","journal-title":"Cancer Cell"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1038\/s41467-025-56462-0","article-title":"Predicting immunotherapy response of advanced bladder cancer through a meta-analysis of six independent cohorts","volume":"16","author":"Boll","year":"2025","journal-title":"Nat Commun"},{"key":"B95","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12943-024-01980-6","article-title":"Tertiary lymphoid structural heterogeneity determines tumour immunity and prospects for clinical application","volume":"23","author":"Zhang","year":"2024","journal-title":"Mol Cancer"},{"key":"B96","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/j.ccell.2026.06.006","article-title":"GABA promotes resistance to immunotherapy in patients with TLS-positive tumors","volume":"44","author":"Hern\u00e1ndez-Verdin","year":"2026","journal-title":"Cancer Cell"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1947028\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T10:54:02Z","timestamp":1789728842000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1947028\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,18]]},"references-count":96,"alternative-id":["10.3389\/fimmu.2026.1947028"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1947028","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,18]]},"article-number":"1947028"}}